Company Registration No. 15261313 (England and Wales)
Testslick Limited
Unaudited accounts
for the period from 6 November 2023 to 30 November 2024
Testslick Limited
Unaudited accounts
Contents
Testslick Limited
Company Information
for the period from 6 November 2023 to 30 November 2024
Directors
Mark Watson
Hugo Miguel Marques Farinha
Company Number
15261313 (England and Wales)
Registered Office
7 High Street
Windsor
SL4 1LD
United Kingdom
Accountants
Blue Cube Accountants Limited
7 High Street
Windsor
SL4 1LD
Testslick Limited
Statement of financial position
as at 30 November 2024
Cash at bank and in hand
127,141
Creditors: amounts falling due within one year
(89,086)
Called up share capital
46,085
Profit and loss account
(274)
Shareholders' funds
145,725
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 July 2025 and were signed on its behalf by
Mark Watson
Director
Company Registration No. 15261313
Testslick Limited
Notes to the Accounts
for the period from 6 November 2023 to 30 November 2024
Testslick Limited is a private company, limited by shares, registered in England and Wales, registration number 15261313. The registered office is 7 High Street, Windsor, SL4 1LD, United Kingdom.
These financial statements have been prepared in compliance with FRS 102, ’The Financial Reporting Standard applicable to the UK and Republic of Ireland’ including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts and rebates.
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation. The software development costs are being amortised of its useful life of 5 years.
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Testslick Limited
Notes to the Accounts
for the period from 6 November 2023 to 30 November 2024
During the period, a total of 1,111,111 share options, representing 9.1% of the total shares in issue, were made available to employees and/or directors. However, these share options were not exercised during the reporting period, and no shares were optioned.
The share options were offered in accordance with the company's share option plan, and the terms and conditions of the options were disclosed to eligible participants. As at the balance sheet date, these share options remained unexercised and therefore did not result in any changes to the issued share capital of the company.
The fair value of the unexercised share options at the balance sheet date has been considered in accordance with FRS 102. Any impact of the share options on the financial statements, including potential dilution or changes in equity, will be disclosed in future periods, should the options be exercised.
Expenditure on research and development is written off in the year in which it is incurred.
3
Intangible fixed assets
Other
At 30 November 2024
88,709
Charge for the period
7,275
At 30 November 2024
81,434
Amounts falling due within one year
5
Creditors: amounts falling due within one year
2024
Loans from directors
86,186
Testslick Limited
Notes to the Accounts
for the period from 6 November 2023 to 30 November 2024
Allotted, called up and fully paid:
10,854,700 Ordinary shares of £0.0001 each
1,085.47
249,998 Ordinary B shares of £0.18 each
44,999.64
Shares issued during the period:
10,854,700 Ordinary shares of £0.0001 each
1,085.47
249,998 Ordinary B shares of £0.18 each
44,999.64
7
Average number of employees
During the period the average number of employees was 0.